NetTargets and Cellkey sign MoU to collaborate on biomarker discovery

NetTargets Inc.

09 Jun 2021

NetTargets has partnered with Cellkey, which provides a cutting-edge AI-based glycopeptide analysis platform, to discover biomarkers for early detection and treatment of cancer.

NetTargets will present at KASBP's eSymposium on June 4.

Jaehong Shin, CDO of NetTargets will present at Korean American Society in Biotech and Pharmaceuticals (KASBP) eSymposium on June 4, 2021 about computational approaches for early phase drug discovery research in the age of AI.

NetTargets Inc. is selected as one of 25 notable AI startups in 2021 by AI Times.

AI Times recognized NetTargets as one of the notable AI startups in biopharmaceuticals in 2021.

NetTargets Inc. is selected as one of TOP 10 BIOTECH STARTUPS IN APAC 2020 by Startupcity magazine.

We are pleased to be one of top 10 biotech startsups in APAC 2020 selected by Startupcity magazine.

Comming soon

Our next news and events are coming soon

Comming soon

Our next news and events are coming soon

Comming soon

Our next news and events are coming soon

BACK TO THE LIST

SITEMAP

CONTACT US